How Modern Central Pharmacy Service Centers Drive Enterprise Pharmacy Performance

The stakes have never been higher for health systems operating under unprecedented operational and financial pressure. Margin compression, increasing labor volatility, supply chain fragility, and the rapid shift of care toward ambulatory, virtual, and home-based settings are forcing leaders to rethink traditional operating models, particularly Central Pharmacy Service Centers (CSCs).

A modern CSC is not a single function or facility, but a coordinated platform that integrates multiple enterprise capabilities into a unified operating model. They provide the infrastructure required to standardize core processes and expand specialty and infusion therapy capabilities. Just as importantly, they enable pharmacists to focus more of their time on clinical practice.

In this new reality, the CSC model has emerged as a critical asset for enterprise strategy, not simply for cost reduction, but infrastructure enabling scalability, resilience, and clinical transformation.

The Strategic Evolution of CSCs

While the concept of centralization has existed for decades, these models historically focused on consolidating discrete activities, such as unit dose packaging or central fill, to reduce duplication and lower labor costs. While effective in narrow applications, these early iterations were largely transactional in nature and limited in their strategic impact.

Today’s medication distribution environment is defined by fragmented care settings, high-cost specialty therapies, site-of-care shifts, and increasing regulatory oversight. The logistical challenge now extends far beyond moving product. Health systems must coordinate a dynamic, multi-site ecosystem where timing, accuracy, compliance, and cost are tightly interconnected.

Centralization has evolved from an efficiency tactic into a structural necessity.

Health systems must coordinate a dynamic, multi-site ecosystem where timing, accuracy, compliance, and cost are tightly interconnected. Centralization has evolved from an efficiency tactic into a structural necessity.

Modern CSCs represent a shift from task consolidation to enterprise orchestration and coordination. Rather than functioning as isolated operational hubs, they serve as system-wide control layers that standardize processes, align decision-making, and create visibility across the medication-use continuum. This evolution reflects a broader transformation in health system strategy, one that prioritizes scalability, resilience, and integration over localized autonomy.

As a result, CSCs now enable capabilities that extend well beyond traditional pharmacy operations.

• They support enterprise-wide standardization by reducing variability in workflows, protocols, and inventory practices across sites.
• They enable system-wide labor optimization by pooling resources and redistributing work based on demand rather than geography.
• They create the operational backbone required to expand specialty pharmacy, infusion services, and care-at-home models, all increasingly central to both clinical and financial

More importantly, CSCs provide a mechanism for health systems to manage complexity without being overwhelmed by it. By centralizing high-variability, high-volume, and non-patient-facing activities, organizations can simplify frontline environments while simultaneously increasing overall system capability.

In this way, CSCs directly address many of the structural pressures of the modern healthcare landscape. They help health systems preserve operations under stress while building the infrastructure needed to support future care models.

The Modern Central Pharmacy Service Center

Centralized pharmacy operations are at the core of the CSC model. High-volume, repeatable activities such as prescription fulfillment, sterile and non-sterile compounding, packaging, and verification are aggregated into a controlled environment where throughput, quality, and standardization can be optimized. This shift reduces redundancy across sites while improving accuracy and turnaround times.

Layered over these operations is enterprise supply chain management. Procurement, inventory optimization, shortage mitigation, and allocation management are coordinated centrally. This move away from fragmented, site-level decision-making is particularly critical when drug shortages, allocation constraints, and pricing volatility require rapid, data-driven responses. Centralized control enables better strategic purchasing and inventory positioning, as well as reduces waste across the network.

Technology and analytics form the connective tissue of the CSC. Advanced forecasting models, real-time inventory visibility, and integration with Electronic Health Records (EHRs) and supplier systems allow for proactive rather than reactive operations. This includes demand planning based on clinical utilization trends, predictive modeling for shortages, and alignment between purchasing and actual patient need, an area that is particularly relevant in managing 340B virtual inventory environments.

Workforce optimization is another defining pillar. CSCs allow organizations to transition from rigid, site-based staffing models to more flexible, demand-driven labor pools. Pharmacists and technicians can be deployed based on system-wide needs, supported by standardized workflows and centralized oversight. This not only improves productivity but also reduces burnout and variability in staffing coverage.

Finally, centralized regulatory oversight ensures consistent compliance across an increasingly complex landscape. This includes Drug Supply and Chain Security Act traceability, controlled substance management, multi-state licensure, and audit readiness. By consolidating these responsibilities, CSCs reduce risk exposure while improving the organization’s ability to respond to evolving regulatory requirements.

Collectively, these functions transform the CSC from a physical location into an enterprise platform. By offloading routine, high-volume operational work, CSCs allow local pharmacy teams to shift their focus toward clinical services, patient engagement, and value-based care initiatives. Centralization, in this context, is a reallocation of focus toward higher-value activities, rather than a relocation of tasks.

Key Capabilities of Modern CSCs

Next-generation CSCs distinguish themselves through modularity and alignment with broader enterprise strategy. Unlike legacy models designed around fixed functions, modern CSCs are built to evolve alongside the organization, enabling new capabilities as priorities shift:

• High-volume prescription fulfillment and integrated mail. By centralizing dispensing and leveraging automated technologies, CSCs can support large-scale ambulatory and retail pharmacy growth without requiring proportional expansion at individual sites. This is particularly important as health systems seek to capture prescription leakage and expand access through home delivery models.
• Centralized sterile and non-sterile compounding. CSCs can achieve higher levels of quality control, throughput, and compliance by aggregating compounding activities into specialized environments. This is especially relevant for hazardous drug handling, batch compounding, and infusion preparation, where consistency and safety are paramount.
• Specialty pharmacy hub functions. These include limited distribution drug (LDD) coordination, prior authorization support, patient onboarding, and financial assistance. Centralizing these activities allows health systems to better manage the complexity of specialty therapies while improving patient access and It also creates a more integrated model between dispensing, clinical management, and reimbursement optimization.
• Patient engagement and call center. As centralized access points for patients, CSCs help in coordinating refill reminders, therapy education, adherence support, and scheduling. This improves the patient experience while creating more opportunities for proactive, longitudinal care management.
• Enterprise-wide purchasing and allocation management. CSCs can act as the central node for managing shortages, reallocating inventory, and coordinating system-wide responses to supply disruptions. This capability enables more strategic control over drug spend and availability, which is critical given the frequency and severity of drug
• Integrated home delivery and last-mile logistics models. Extending the reach of the health system beyond traditional care settings, CSCs enable direct-to-patient distribution, supporting care-at-home initiatives, post-discharge medication access, and chronic disease management programs.

A modular approach ensures that CSCs remain adaptable and provide a foundation upon which new services can be layered, whether expanding into home infusion or other emerging value-based care models.

The evolution of CSCs reflects a broader reality: sustainable growth requires operating models that can scale with increasing complexity. By creating a centralized foundation for pharmacy services, CSCs enable health systems to achieve more for patient care, both today and tomorrow.

In the next article, we will take a deeper look at how leading organizations approach CSC transformation. We'll share the McKesson approach to building and optimizing these models, potential financial and operational value, and our strategic recommendations for health systems considering this journey.